Enhanced Group announced a private placement of 12,853,468 Class A shares with accompanying warrants at $3.89 per share for expected gross proceeds of about $50 million, closing in three tranches starting on or about June 17, 2026. A portion of the proceeds will be used to repay in full a working capital promissory note held by Apeiron, which will then terminate without penalties. The company also executed a registration rights agreement to register the resale of the shares and warrant shares, supporting investor liquidity. Management expects the financing to strengthen liquidity and accelerate growth of its telehealth and consumer health platform.

Agreement 1: Enhanced Group Raises $50 Million in Private Placement Priced at $3.89 With Warrants

• Agreement type: Securities Purchase Agreement for private placement of common stock and warrants
• Counterparty: Multiple investors including Apeiron Investment Group and Maximilian Martin
• Signed / Effective: Jun 14 2026 / Jun 14 2026
• Reason: Raise growth capital and refinance working capital note

Agreement 2: Enhanced Group Enters Registration Rights Agreement to Register Private Placement Securities

• Agreement type: Registration Rights Agreement for resale of shares and warrant shares
• Counterparty: Investors in the private placement
• Signed / Effective: Jun 14 2026 / Jun 14 2026
• Duration / Termination: Until resale registration effective
• Reason: Facilitate liquidity for investors

Agreement 3: Enhanced Group to Repay and Terminate Apeiron Working Capital Note After First Closing

• Agreement terminated: Working Capital Promissory Note
• Counterparty: Apeiron Investment Group
• Original agreement date: Mar 18 2026
• Termination date: Jun 18 2026
• Termination type: Early
• Exit fees / payments: None
• Reason: Repay related-party working capital note using placement proceeds

Original SEC Filing: Enhanced Group Inc. [ ENHA ] - 8-K - Jun. 15, 2026